1 completed. 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Completed 1 |
Follow Hepalatide 4.2mg: new trials by email Literature Review of Hepalatide 4.2mg trials Research Report on Hepalatide 4.2mg
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Phase II Study of Hepalatide in Subjects With Chronic Hepatitis B Hepalatide 2.1mg, Hepalatide 4.2mg, Hepalatide 6.3mg - Hepatitis B, Chronic | Phase 2 | Completed | Shanghai HEP Pharmaceutical Co., Ltd. | 96 | 2021-06-18 | 2025-01-27 |
Shanghai HEP Pharmaceutical Co., Ltd. (1)
China (1)
Fusheng Wang (1)